Epigenomic erosion linked to cognitive decline in Alzheimer’s patients
AI si Robotica
Picower Institute at MIT Sep 2 2025 Most people recognize Alzheimer's from its devastating symptoms such as memory loss, while new drugs target pathological aspects of disease manifestations, such as plaques of amyloid proteins. Now a sweeping new study in the Sept. 4 edition of Cell by MIT researchers shows the importance of understanding the disease as a battle over how well brain cells control the expression of their genes. The study paints a high-resolution picture of a desperate struggle
din zilele anterioare